Comparative in vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes

References

• Denise H, Barrett MP. Uptake and mode of action of drugs used against sleeping sickness. Biochem Pharmacol. 2001;61:1–5.
   PubMed Web of Science ®Google Scholar
• Thuita JK, Wolf KK, Murilla GA, et al. Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of Human African Trypanosomiasis. PLoS Negl Trop Dis. 2013;7:e2230.
   PubMed Web of Science ®Google Scholar
• Aksoy S, Buscher P, Lehane M, et al. Human African trypanosomiasis control: achievements and challenges. PLoS Negl Trop Dis. 2017;11:1–6.
   Web of Science ®Google Scholar
• Aksoy S, Attardo G, Berriman M, et al. Human African trypanosomiasis research gets a boost: unraveling the Tsetse genome. PLoS Negl Trop Dis. 2014;8:6–8.
   Web of Science ®Google Scholar
• Babokhov P, Sanyaolu AO, Oyibo WA, et al. A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis. Pathog Glob Health. 2013;107:242–252.
   PubMed Web of Science ®Google Scholar
• Mäser P, Lüscher A, Kaminsky R. Drug transport and drug resistance in African trypanosomes. Drug Resistance. Drug Resist Updat. 2003;6:281–290.
   PubMed Web of Science ®Google Scholar
• Sanderson L, Dogruel M, Rodgers J, et al. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein. J Pharmacol Exp Therapeut. 2009;329:967–977.
   PubMed Web of Science ®Google Scholar
• Etchegorry MG, Helenport JP, Pecoul B, et al. Availability and affordability of treatment for Human African Trypanosomiasis. Trop Med Int Health. 2001;6:957–959.
   PubMed Web of Science ®Google Scholar
• Arias JL, Unciti-Broceta JD, Maceira J, et al. Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis. J Control Release. 2015;197:190–198.
   PubMed Web of Science ®Google Scholar
• Aksoy S, Maudlin I, Dale C, et al. Prospects for control of African trypanosomiasis by tsetse vector manipulation. Parasitol Today. 2001;17:29–35.
   Google Scholar
• Porcheddu A, Giacomelli G, De Luca L. New pentamidine analogues in medicinal chemistry. Curr Med Chem. 2012;19:5819–5836.
   PubMed Web of Science ®Google Scholar
• Baker N, de Koning HP, Mäser P, et al. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Trends Parasitol. 2013;29:110–118.
   PubMed Web of Science ®Google Scholar
• Lin JM-H, Shi RJ, Lin ET. High performance liquid chromatographic determination of pentamidine in plasma. J Liq Chromatogr. 1986;9:9:2035–2046.
   Web of Science ®Google Scholar
• Soeiro MNC, Werbovetz K, Boykin DW, et al. Novel amidines and analogues as promising agents against intracellular parasites: a systematic review. Parasitology. 2013;140:929–951.
   PubMed Web of Science ®Google Scholar
• Burri C. Chemotherapy against human African trypanosomiasis: is there a road to success?. Parasitology. 2010;137:1987–1994.
   PubMed Web of Science ®Google Scholar
• Wilson WD, Tanious FA, Mathis A, et al. Antiparasitic compounds that target DNA. Biochimie. 2008;90:999–1014.
   PubMed Web of Science ®Google Scholar
• Wenzler T, Boykin DW, Ismail MA, et al. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother. 2009;53:4185–4192.
   PubMed Web of Science ®Google Scholar
• Paul M, Laatiris A, Fessi H, et al. Pentamidine-loaded poly (D, L-lactide) nanoparticles: adsorption and drug release. Drug Dev Res. 1998;43:98–104.
   Web of Science ®Google Scholar
• Dua JS, Rana AC, Bhandari A. K. Review article liposome: methods of preparation and applications. Int J Pharmaceut Stud Res. 2012;III:7.
   Google Scholar
• Ubrich N, Bouillot P, Pellerin C, et al. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study. J Control Release. 2004;97:291–300.
   PubMed Web of Science ®Google Scholar
• Begum MY, Sudhakar M, Abbulu K. Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution. J Young Pharm. 2012;4:209–219.
   PubMedGoogle Scholar
• Sha X, Guo J, Chen Y, et al. Effect of phospholipid composition on pharmacokinetics and biodistribution of epirubicin liposomes. J Liposome Res. 2012;22:80–88.
   PubMed Web of Science ®Google Scholar
• Agrawal M, Ajazuddin, Tripathi DK, et al. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer’s disease. J Control Release. 2017;260:61–77.
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Stainmesse S, et al. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688–1713.
   PubMed Web of Science ®Google Scholar
• Ta HT, Truong NP, Whittaker AK, et al. The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases. Expert Opin Drug Deliv. 2018;15:33–45.
   PubMed Web of Science ®Google Scholar
• Truong NP, Whittaker MR, Mak CW, et al. The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv. 2015;12:129–142.
   PubMed Web of Science ®Google Scholar
• Cohen-Sela E, Chorny M, Koroukhov N, et al. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release. 2009;133:90–95.
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 2002;6:319–327.
   Web of Science ®Google Scholar
• Göppert TM, Müller RH. (Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target. 2005;13:179–187.
   PubMed Web of Science ®Google Scholar
• Limayem Blouza I, Charcosset C, Sfar S, et al. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use. Int J Pharmaceut. 2006;325:124–131.
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, et al. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49:175–186.
   PubMed Web of Science ®Google Scholar
• Chigumira W, Maposa P, Gadaga LL, et al. Preparation and evaluation of pralidoxime-loaded PLGA nanoparticles as potential carriers of the drug across the blood brain barrier. J Nanomater. 2015;2015:1.
   Web of Science ®Google Scholar
• Bordes C, Fréville V, Ruffin E, et al. Determination of poly (Ɛ-caprolactone) solubility parameters: application to solvent substitution in a microencapsulation process. Int J Pharmaceut. 2010;383:236–243.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Valour JP, Fessi H, et al. Preparation of biodegradable PCL particles via double emulsion evaporation method using ultrasound technique. Colloid Polym Sci. 2015;293:861–873.
   Web of Science ®Google Scholar
• Lopes LB, Scarpa MV, Silva GVJ, et al. Studies on the encapsulation of diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf B Biointerfaces. 2004;39:151–158.
   PubMed Web of Science ®Google Scholar
• Srinivasan B, Kolli AR, Esch MB, et al. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20:107–126.
   PubMedGoogle Scholar